IDSA : View All Statements on Emerging Infections

09/14/2012

IDSA Seasonal and Pandemic Influenza Principles for U.S. Action (PDF)

IDSA's Pandemic and Seasonal Influenza Principles for United States Action are to educate and federal policymakers and assist the US Department of Health and Human Services' Assistant Secretary for Preparedness and other agency officials, about how best to prepare for and respond to seasonal and pandemic influenza.

04/02/2012

IDSA Statement on Doxycycline Medkits (PDF)

At a joint meeting of FDA advisory committees regarding development of a doxycycline home MedKit, IDSA provided a public statement on prepositioning in the event of an anthrax release.

09/29/2010

IDSA Testimony on Medical Countermeasures Enterprise Review (PDF)

Dr. Andy Pavia testified on behalf of IDSA at a September 29, 2010 hearing of the Senate Labor-Health and Human Services-Education Appropriations Subcommittee examining the Public Health Emergency Medical Countermeasures Enterprise review completed by the Department of Health and Human Services in August 2010.

10/29/2008

IDSA Statement on the Development of Influenza Antiviral Home MedKits (PDF)

At a meeting of FDA advisory committee regarding development of an influenza antiviral home MedKit, IDSA provided a public statement about the challenges to safe and effective use posed by the unknowns regarding use of current antivirals in a pandemic, combined with the absence of medical supervision in the proposed scenario of home based use.

06/18/2008

IDSA Preliminary Statement on Antibiotic Home Stockpiling (PDF)

At a meeting of the National Biodefense Science Board, IDSA delivered public comments raising concerns about an HHS initiative to inform the public about home stockpiling of doxycycline for use in a potential anthrax attack.

04/06/2006

Project Bioshield Reauthorization (PDF)

Statement from Martin J. Blaser, MD, IDSA President.

01/13/2006

CID Working Group Joint Statement to HHS on Pandemic Influenza (PDF)

In a joint statement to the United States Department of Health and Human Services on January 13, 2006, IDSA recommended solutions to strengthen and improve the U.S. Preparedness and Response Plan against pandemic influenza.

05/26/2005

IDSA Pandemic Influenza Statement by Andrew T. Pavia, MD (PDF)

IDSA's statement by Andrew T. Pavia, MD concerning pandemic influenza given before the House Committee on Energy and Commerce Subcommittee on Health.

11/15/2004

IDSA Statement before HHS Task Force on Stimulating Medical Innovations (PDF)

IDSA urges initiative to stimulate innovation in medical technologies, specifically new drugs, vaccines, and diagnostics to treat, prevent, and detect infectious diseases agents, and for antibiotics to treat resistant bacterial infections as well as new rapid diagnostics to detect them.

04/04/2003

IDSA Statement Concerning “Project Bioshield” (PDF)

IDSA statement concerning “Project Bioshield” presented by John E. Edwards, MD before the Committee on Government Reform U.S. House of Representatives.

06/14/2002

IDSA Statement on Smallpox Plan (PDF)

Policy recommendations concerning the national smallpox vaccine plan.

03/25/1999

IDSA Statement on Bioterrorism (PDF)

Statement of John G. Bartlett, MD, President, Infectious Diseases Society of America before the Subcommittee on Public Health Committee on Health, Education, Labor and Pensions United States Senate on bioterrorism: our front line response in evaluating U.S. public health and medical readiness.